Metraipolis › archive › dc_ee703a15210b
Practical considerations for the use of IL-23p19 inhibitors in inflammatory bowel disease: how to choose between them and why it matters? — Europe PMC PMID:40748696
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40748696
- DOI
- 10.1093/ecco-jcc/jjaf144
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:36:48.656Z
- SHA-256 of the archived text
903c40a38ad404d9e1c23ee76287d1c06d03bfcadd86118374248228c9687b40- Stable URL of this page
https://metraipolis.com/documento/dc_ee703a15210b
How to cite
Practical considerations for the use of IL-23p19 inhibitors in inflammatory bowel disease: how to choose between them and why it matters? — Europe PMC PMID:40748696 — Europe PMC (en), https://europepmc.org/article/MED/40748696 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee703a15210b (Metraipolis archive dc_ee703a15210b, sha256 903c40a38ad404d9e1c23ee76287d1c06d03bfcadd86118374248228c9687b40)
BibTeX
@misc{dcee703a15210b,
title = {Practical considerations for the use of IL-23p19 inhibitors in inflammatory bowel disease: how to choose between them and why it matters? — Europe PMC PMID:40748696},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40748696},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee703a15210b; sha256 903c40a38ad404d9e1c23ee76287d1c06d03bfcadd86118374248228c9687b40},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40748696. Agents can read the archived copy with the MCP tool read_document.